Subtype
Ovarian Neoplasm
CI-CAN-00001335Explore in graph →
Non-malignant746 active trials5 approved drugs94 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001335Explore in graph →
Clinical trials
3,430 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02478476 | DNA Single Nucleotide Polymorphisms as Predictors of Toxicity | unknown | — | 75 | OvaGene Oncology, Inc.INDUSTRY | 1 | Jun 23, 2015 | clinicaltrials |
| NCT02458001 | Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer(SAFFRON) | unknown | N/A | 100 | University College, LondonOTHER | 0 | May 29, 2015 | clinicaltrials |
| NCT02188550 | Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer | unknown | Phase 2 | 20 | Sinai Hospital of BaltimoreOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT02435186 | p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer | unknown | Phase 2 | 100 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | May 6, 2015 | clinicaltrials |
| NCT01715168 | A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer | unknown | Phase 1 | 40 | Azaya Therapeutics, Inc.INDUSTRY | 2 | Jan 15, 2015 | clinicaltrials |
| NCT01187602 | Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer(sncRNA) | unknown | — | 103 | University of VirginiaOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT01628380 | Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer(CHORINE) | unknown | Phase 3 | 94 | A.O. Ospedale Papa Giovanni XXIIIOTHER | 2 | Aug 28, 2014 | clinicaltrials |
| NCT00410462 | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | unknown | Phase 2 | 118 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00004206 | Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer | unknown | Phase 2 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT02132988 | Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer | unknown | Phase 2 | 110 | Mackay Memorial HospitalOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT01334437 | Blood Test for Ovarian Cancer Associated Auto Antibodies | unknown | — | 250 | Eventus Diagnostics LtdINDUSTRY | 1 | Feb 20, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00003064 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer | unknown | Phase 1 / Phase 2 | 30 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003560 | Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | unknown | Phase 2 | 40 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003718 | Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma | unknown | Phase 2 | 25 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00002477 | Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer | unknown | Phase 3 | — | Medical Research CouncilOTHER_GOV | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00021385 | Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer | unknown | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00004064 | Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer | unknown | Phase 2 | 102 | AltaRexINDUSTRY | 2 | Nov 6, 2013 | clinicaltrials |
| NCT00005025 | Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | unknown | Phase 2 | — | John Stoddard Cancer Center at Iowa Methodist Medical CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00017303 | Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer | unknown | Phase 2 | — | CytranINDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01470235 | Hypodontia and Ovarian Cancer | unknown | — | 200 | University of AarhusOTHER | 1 | Nov 1, 2013 | clinicaltrials |
| NCT00003733 | Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer | unknown | Phase 2 | 40 | SmithKline BeechamINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00036712 | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation | unknown | Phase 2 | 80 | Medical College of WisconsinOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00897039 | Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | unknown | — | 60 | Southeastern Gynecologic OncologyOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00002487 | Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer | unknown | Phase 2 | — | Ottawa Regional Cancer CentreOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00004115 | Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy | unknown | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00274950 | Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | unknown | Phase 3 | 105 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 17, 2013 | clinicaltrials |
| NCT00276718 | Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors | unknown | N/A | 100 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 17, 2013 | clinicaltrials |
| NCT00601406 | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | unknown | N/A | 2,200 | The Christie NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00757263 | Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 2,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00964626 | Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | unknown | Phase 2 | 60 | Russian Academy of Medical SciencesOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01100372 | Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | unknown | Phase 2 | 154 | Medical University InnsbruckOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01388621 | Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer(PROVE) | unknown | Phase 2 | 140 | WiSP Wissenschaftlicher Service Pharma GmbHOTHER | 1 | Aug 20, 2013 | clinicaltrials |
| NCT00305838 | CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen | unknown | Phase 2 | 200 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00436774 | Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01 | unknown | — | 60 | Children's Cancer and Leukaemia GroupOTHER | 2 | Aug 12, 2013 | clinicaltrials |
| NCT00045461 | Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | unknown | Phase 2 / Phase 3 | 241 | Ludwig-Maximilians - University of MunichOTHER | 3 | Aug 7, 2013 | clinicaltrials |
| NCT00886717 | Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer | unknown | Phase 1 / Phase 2 | 74 | Asan Medical CenterOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01888159 | Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve | unknown | N/A | 100 | Karlstad Central HospitalOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT00039559 | Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer | unknown | N/A | 2,430 | Massachusetts General HospitalOTHER | 1 | Jun 10, 2013 | clinicaltrials |
| NCT01823731 | A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index | unknown | — | 50 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 5, 2013 | clinicaltrials |
| NCT01456065 | Safety of Active Immunotherapy in Subjects With Ovarian Cancer | unknown | Phase 1 | 15 | Life Research Technologies GmbHOTHER | 2 | Mar 1, 2013 | clinicaltrials |
| NCT01387399 | Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer(HIPEC ROC I) | unknown | Phase 1 | 9 | University Hospital, BonnOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00900289 | Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | unknown | — | 1,000 | Liz-Anne LewsleyOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT01779128 | PET-CT vs. Integrated MR-PET Scanning of GYN Cancers | unknown | Early Phase 1 | 100 | Massachusetts General HospitalOTHER | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00551122 | Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors(GemTIP) | unknown | Phase 1 / Phase 2 | 23 | University of SouthamptonOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01770535 | Oxford Ovarian Cancer Predict Chemotherapy Response 01(OXO-PCR-01) | unknown | — | 35 | University of OxfordOTHER | 1 | Jan 17, 2013 | clinicaltrials |
| NCT01724944 | LYmphadenectomy After NeoAdjuvant Chemotherapy(LYANA) | unknown | Phase 1 / Phase 2 | 65 | Catholic University of the Sacred HeartOTHER | 1 | Nov 12, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jun 23, 2015source: clinicaltrials